| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Silibinin | Acute Lung Injury | 1 | PM | 28483599 | 📋 | Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways |
| Silibinin | Anaphylaxis | 1 | PM | 37115717 | 📋 | Silibinin attenuated pseudo-allergic reactions and mast cell degranulation via PLCγ and PI3K/Akt signaling pathway |
| Silibinin | COPD | 1 | PM | 28602599 | 📋 | Silibinin inhibits the fibrotic responses induced by cigarette smoke via suppression of TGF-β1/Smad 2/3 signaling |
| Silibinin | Lung Cancer | 11 | PM | 38484626 | 📋 | Silibinin is a suppressor of the metastasis-promoting transcription factor ID3 |
| Silibinin | Lung Cancer | 8 | PM | 36551587 | 📋 | Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors |
| Silibinin | Lung Cancer | 7 | PM | 34611448 | 📋 | Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer |
| Silibinin | Lung Cancer | 6 | PM | 34439322 | 📋 | Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer |
| Silibinin | Lung Cancer | 5 | PM | 34209829 | 📋 | Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells |
| Silibinin | Lung Cancer | 4 | PM | 34208282 | 📋 | Lung Cancer Management with Silibinin: A Historical and Translational Perspective |
| Silibinin | Lung Cancer | 2 | PM | 33935737 | 📋 | Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma |
| Silibinin | Lung Cancer | 1 | PM | 33362957 | 📋 | Transcriptome profiling reveals Silibinin dose-dependent response network in non-small lung cancer cells |
| Silibinin | Lung Cancer | 3 | PM | 32528541 | 📋 | Silibinin Suppresses Epithelial-Mesenchymal Transition in Human Non-Small Cell Lung Cancer Cells by Restraining RHBDD1 |
| Silibinin | Lung Cancer | 10 | PM | 23879966 | 📋 | Silibinin reverses drug resistance in human small-cell lung carcinoma cells |
| Silibinin | Lung Cancer | 9 | PM | 23461975 | 📋 | Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells |
| Silibinin | Lung Inflammation | 1 | PM | 34250649 | 📋 | Silibinin alleviates silica-induced pulmonary fibrosis: Potential role in modulating inflammation and epithelial-mesenchymal transition |
| Silibinin | Nasopharyngeal Cancer | 1 | PM | 32679194 | 📋 | Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism |
| Silibinin | Oral Cancer | 4 | PM | 37476191 | 📋 | Silibinin induces oral cancer cell apoptosis and reactive oxygen species generation by activating the JNK/c-Jun pathway |
| Silibinin | Oral Cancer | 1 | PM | 32711410 | 📋 | Silibinin Triggers the Mitochondrial Pathway of Apoptosis in Human Oral Squamous Carcinoma Cells |
| Silibinin | Oral Cancer | 2 | PM | 32678829 | 📋 | Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model |
| Silibinin | Oral Cancer | 3 | PM | 16498067 | 📋 | Silibinin Inhibits Invasion of Oral Cancer Cells by Suppressing the MAPK Pathway |
| Silibinin | Pulmonary Fibrosis | 1 | PM | 34250649 | 📋 | Silibinin alleviates silica-induced pulmonary fibrosis: Potential role in modulating inflammation and epithelial-mesenchymal transition |
| Silibinin | Pulmonary Hypertension | 1 | PM | 32455728 | 📋 | Silibinin Upregulates CXCR4 Expression in Cultured Bone Marrow Cells (BMCs) Especially in Pulmonary Arterial Hypertension Rat Model |
